Literature DB >> 23904808

Red blood cell and leukocyte alloimmunization in patients awaiting kidney transplantation.

Silvia Fernandes Ribeiro da Silva1, Gláucia Maria Ferreira, Sonia Leite da Silva, Tânia Maria de Oliveira Alves, Ilana Farias Ribeiro, Thyciana Rodrigues Ribeiro, Maria do Carmo Serpa Cavalcante.   

Abstract

OBJECTIVE: To determine the rates of red blood cell and leukocyte alloimmunization in patients with chronic kidney disease awaiting kidney transplantation.
METHODS: In this cross-sectional and prospective study, the serum of 393 chronic kidney disease patients on a transplant waiting list in Ceará, Northeastern Brazil were tested for red cell and leukocyte antibodies. In addition, demographic, clinical and laboratory data were collected.
RESULTS: The average age in the sample of 393 patients was 34.1 ± 14 years. Slightly more than half (208; 52.9%) were male. The average numbers of transfusions and gestations were 3.1 ± 3.3 and 1.6 ± 6, respectively. One third (33.6%) were alloimmunized: 78% with leukocyte antibodies, 9.1% with red cell antibodies and 12.9% with both. Red cell antibodies were detected in 29 cases (7.4%), 17 of whom were women, who had received more transfusions than the males (p-value < 0.0001). The most frequently detected red cell antibodies belonged to the Rh (24.1%) and Kell (13.8%) blood group systems. Leukocyte antibodies were detected in 30.5% of cases, 83 of whom were women, who had received more transfusions than the males (p-value < 0.0001) and were more reactive to panel reactive antibodies (p-value < 0.0001). The mean alloreactivity to panel reactive antibodies was 47.7 ± 31.2%.
CONCLUSION: Chronic kidney disease patients on the transplant waiting list in Ceará, Brazil, display high rates of red cell (7.4%) and leukocyte (30.5%) alloimmunization. In this sample, alloimmunization was significantly associated with the number of transfusions and gender.

Entities:  

Keywords:  Antibodies; Blood transfusion; Cross-sectional studies; Erythrocyte transfusion; Kidney failure, chronic; Kidney transplantation

Year:  2013        PMID: 23904808      PMCID: PMC3728131          DOI: 10.5581/1516-8484.20130043

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN: 1516-8484


  6 in total

1.  Risk factors for alloimmunization by patients with sickle cell disease.

Authors:  M Murao; M B Viana
Journal:  Braz J Med Biol Res       Date:  2005-05-25       Impact factor: 2.590

Review 2.  Red cell exchange in sickle cell disease.

Authors:  Paul S Swerdlow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

3.  Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.

Authors:  G Moreira Júnior; J O Bordin; A Kuroda; J Kerbauy
Journal:  Am J Hematol       Date:  1996-07       Impact factor: 10.047

4.  Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group.

Authors:  L M Williamson; J Z Wimperis; P Williamson; J A Copplestone; H C Gooi; G R Morgenstern; D R Norfolk
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

Review 5.  Detection of HLA-antibodies prior to renal transplantation: prospects and limitations of new assays.

Authors:  Patrizia Amico; Gideon Hönger; Michael Mayr; Stefan Schaub
Journal:  Swiss Med Wkly       Date:  2008-08-23       Impact factor: 2.193

Review 6.  Humoral rejection of human organ transplants.

Authors:  Paul J Michaels; Michael C Fishbein; Robert B Colvin
Journal:  Springer Semin Immunopathol       Date:  2003-09
  6 in total
  3 in total

1.  Red cell and human leukocyte antigen alloimmunization in candidates for renal transplantation: a reality.

Authors:  Mariza Aparecida Mota
Journal:  Rev Bras Hematol Hemoter       Date:  2013

2.  Evaluation of the humoral immune response to human leukocyte antigens in Brazilian renal transplant candidates.

Authors:  Patricia Keiko Saito; Roger Haruki Yamakawa; Erica Pereira Aparecida; Waldir Verissimo da Silva Júnior; Sueli Donizete Borelli
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

3.  Red blood cell alloimmunization in multi-transfused patients with chronic kidney disease in Port Harcourt, South-South Nigeria.

Authors:  Esther Ifeoma Obi; Crosdale Ogho Pughikumo; Richard Ishmael Oko-Jaja
Journal:  Afr Health Sci       Date:  2018-12       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.